Literature DB >> 11235947

Combined endovascular treatment of dissecting vertebral artery aneurysms by using stents and coils.

P Lylyk1, J E Cohen, R Ceratto, A Ferrario, C Miranda.   

Abstract

OBJECT: With the recent development and refinement of endovascular stents, the significant potential for these devices in the treatment of wide-necked dissecting and fusiform aneurysms has become apparent. In this article the authors report on the use of stents and coils to treat dissecting and fusiform vertebral artery (VA) aneurysms.
METHODS: Eight consecutive patients harboring eight dissecting aneurysms and one fusiform aneurysm of the VA were succesfully treated using a procedure in which the authors inserted an intravascular stent and secondary endosaccular coils when needed. In all but one patient complete aneurysm occlusion was achieved, and in all cases there was no neurological complication. Follow-up angiography examinations were performed in all patients (mean duration of follow-up angiography review 13.1 months, range 3-42 months). The patients remained stable throughout the clinical follow-up period (mean 14.1 months, range 4-42 months). No rebleeding was recorded.
CONCLUSIONS: At present this combined approach represents a reliable and safe alternative for the treatment of VA dissecting aneurysms, especially in patients who cannot tolerate occlusion tests.

Entities:  

Mesh:

Year:  2001        PMID: 11235947     DOI: 10.3171/jns.2001.94.3.0427

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  41 in total

1.  Extracranial Revascularization Therapy: Angioplasty and Stenting.

Authors:  Alexander V. Khaw; H. Christian Schumacher; Philip M. Meyers; Rishi Gupta; Randall T. Higashida
Journal:  Curr Treat Options Cardiovasc Med       Date:  2004-06

2.  Treatment of vertebro-basilar dissecting aneurysms using intravascular stents.

Authors:  S Yamasaki; K Hashimoto; Y Kawano; M Yoshimura; T Yamamoto; M Hara
Journal:  Interv Neuroradiol       Date:  2006-06-15       Impact factor: 1.610

3.  Use of neuroform stent in a patient with acute stroke caused by spontaneous petrous segment internal carotid artery dissection: a case report.

Authors:  D Mitra; A Herwadkar; A Gholkar
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

4.  Dissection of the distal vertebral artery treated by modified parent artery trapping and a contralateral stent barricade. A case report.

Authors:  C-W Ryu; J-S Koh; E-J Kim
Journal:  Interv Neuroradiol       Date:  2010-07-19       Impact factor: 1.610

5.  A novel flexible, retrievable endovascular stent system for small-vessel anatomy: preliminary in vivo data.

Authors:  Arnd Doerfler; Wolfgang P H Becker; Isabel Wanke; Sophia L Goericke; K M Mueller; Nina Blechschmid; Achim Flesser; Hermann Monstadt; Michael Forsting
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

6.  Vertebrobasilar dissection with subarachnoid hemorrhage: a retrospective study of 29 patients.

Authors:  B Ramgren; M Cronqvist; B Romner; L Brandt; S Holtås; E-M Larsson
Journal:  Neuroradiology       Date:  2005-02-16       Impact factor: 2.804

Review 7.  Stents for intracranial wide-necked aneurysms: more than mechanical protection.

Authors:  Isabel Wanke; Michael Forsting
Journal:  Neuroradiology       Date:  2008-09-20       Impact factor: 2.804

8.  Intracranial vertebral artery dissections: evolving perspectives.

Authors:  M S Ali; P S Amenta; R M Starke; P M Jabbour; L F Gonzalez; S I Tjoumakaris; A E Flanders; R H Rosenwasser; A S Dumont
Journal:  Interv Neuroradiol       Date:  2012-12-03       Impact factor: 1.610

9.  Extracranial vertebral artery aneurysm presenting as a chronic cervical mass lesion.

Authors:  Lampis C Stavrinou; George Stranjalis; Pantelis C Stavrinou; N Bontozoglou; Damianos E Sakas
Journal:  Case Rep Med       Date:  2010-04-06

10.  Cervicocranial arterial dissection.

Authors:  Qaisar Shah; Steven R Messé
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.